Skip to content
10-K

Annual Report

Bio Essence Corp BIOE

0001013762-25-003850

← back to feed
Filed
Mar 28, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2024 · Mar 28, 2025 38.01M sh
Long Term Debt FY 2024 · Dec 31, 2024 $56.48K
Cash And Equivalents FY 2024 · Dec 31, 2024 $1.37K
Eps Diluted FY 2024 · Dec 31, 2024 −$0.03
Eps Diluted restated FY 2024 · Dec 31, 2023 −$0.03
Eps Basic FY 2024 · Dec 31, 2024 −$0.03
Eps Basic restated FY 2024 · Dec 31, 2023 −$0.03
Capex FY 2024 · Dec 31, 2023 $3.61K
Operating Cash Flow restated FY 2024 · Dec 31, 2023 −$1.03M
Current Liabilities restated FY 2024 · Dec 31, 2023 $2.45M
Total Liabilities restated FY 2024 · Dec 31, 2023 $4.42M
Current Assets restated FY 2024 · Dec 31, 2023 $300K
Total Assets restated FY 2024 · Dec 31, 2023 $2.76M
Sga Expense restated FY 2024 · Dec 31, 2023 $345.59K
Net Income FY 2024 · Dec 31, 2023 −$971.88K
Operating Income restated FY 2024 · Dec 31, 2023 −$345.59K
Stockholders Equity FY 2024 · Dec 31, 2022 −$3.24M